10-Q: Palladyne AI Reports Q3 2025 Results, Focuses on AI Software
Quarterly Report
Palladyne AI Corp. reported a reduced net loss for Q3 2025 and a net income for the nine-month period, driven by non-cash warrant gains, as it continues its strategic pivot to AI/ML software commercialization.
Summary
- Net loss for the three months ended September 30, 2025, was $3.74 million, an improvement from a net loss of $7.10 million in the same period of 2024.
- Net income for the nine months ended September 30, 2025, was $11.53 million, compared to a net loss of $19.65 million in the prior year, primarily due to a significant non-cash gain on warrant liabilities.
- Revenue, net, for Q3 2025 was $0.86 million, a slight decrease from $0.87 million in Q3 2024.
- Revenue, net, for the nine months ended September 30, 2025, decreased by 49% to $3.58 million from $7.03 million in the prior year, largely due to the cessation of legacy hardware product sales.
- Operating expenses for Q3 2025 increased to $8.93 million from $8.17 million in Q3 2024, driven by a 22% rise in research and development costs.
- Cash, cash equivalents, and marketable securities increased to $57.1 million as of September 30, 2025, from $40.1 million at December 31, 2024.
- The company reported an accumulated deficit of $479.3 million and working capital of $56.0 million as of September 30, 2025.
- Net cash used in operating activities for the nine months ended September 30, 2025, was $19.13 million, an increase from $17.53 million in the prior year.
- Approximately $61.4 million in gross proceeds were raised from the sale of Common Stock and warrants during Q4 2024 and the first three quarters of 2025.
- The company's backlog, or remaining performance obligations, was $0.8 million as of September 30, 2025, with most expected to be recognized over the next 12 months.
Sentiment
Score: 4
Explanation: While the company shows improved quarterly net loss and a nine-month net income (driven by non-cash warrant gains), core operational revenue is significantly down year-over-year, and cash burn from operations continues. The company is in the early stages of commercializing new AI/ML software with long, uncertain sales cycles and faces substantial risks including intense competition and regulatory uncertainty. Recent capital raises provide liquidity, but profitability from core business is still a distant prospect.
Positives
- Net loss for Q3 2025 decreased to $3.74 million from $7.10 million in Q3 2024.
- Achieved a net income of $11.53 million for the nine months ended September 30, 2025, compared to a net loss of $19.65 million in the prior year, largely due to non-cash gains on warrant liabilities.
- Cash, cash equivalents, and marketable securities increased significantly to $57.1 million as of September 30, 2025, from $40.1 million at December 31, 2024.
- Successfully raised approximately $61.4 million in gross proceeds from equity and warrant sales since Q4 2024, bolstering liquidity.
- Product development contract revenue increased by 13% in Q3 2025, indicating progress in its core AI/ML technology development.
- Management believes it has sufficient financial resources to support operations for at least the next 12 months.
- Timely met all development milestones associated with U.S. government contracts.
- Received Level 2 certification for Cybersecurity Maturity Model Certification (CMMC) program requirements on April 10, 2025, enhancing eligibility for government contracts.
Negatives
- Continues to incur operating losses and negative cash flows from operations since inception, with an accumulated deficit of $479.3 million as of September 30, 2025.
- Total revenue for the nine months ended September 30, 2025, decreased by 49% year-over-year, primarily due to the discontinuation of legacy hardware product sales.
- No product revenue has yet been generated from the new AI/ML software products (Palladyne IQ and Palladyne Pilot).
- Net cash used in operating activities increased to $19.13 million for the nine months ended September 30, 2025, indicating continued cash burn from core operations.
- The company is an early-stage software commercialization entity with no prior experience in this specific market.
- Sales cycles for Palladyne IQ are estimated to be long (12-18 months or more), and unknown for Palladyne Pilot, delaying commercial revenue generation.
- The current government shutdown has caused delays in interactions with government agencies, potentially impacting revenues for fiscal years 2025 and 2026.
Risks
- The company is an early-stage entity with a history of losses and expects to incur significant losses for the foreseeable future.
- Operating and financial projections rely on management assumptions that have often proven incorrect in the past, potentially leading to materially different actual results.
- The company has not achieved positive operating cash flow, and its ability to do so is uncertain.
- Lack of previous history or experience with commercializing software products, following unsuccessful efforts with hardware technologies.
- Successful commercialization of AI/ML Foundational Technology and related products may be delayed beyond current expectations, impacting product availability, customer acquisition, and revenue.
- Anticipated revenues are expected to be primarily derived from licensing AI/ML software products, leading to revenue concentration risk.
- Issues in the development and use of AI/ML Foundational Technology or related products, or issues in products developed by others, may result in reputational harm or liability.
- The AI/ML Foundational Technology and related products are new technologies, making the timing and magnitude of revenues from customers uncertain.
- Risk of ceasing business operations if material revenues are not generated before financial resources are exhausted.
- Potential failure to attract or retain customers at sufficient rates or in sufficient numbers.
- Lack of previous history with the licensing sales model.
- Important assumptions about market demand, pricing, adoption rates, and sales cycles for software products may be inaccurate.
- Dependence on single, sole, or limited source suppliers for certain limited hardware components required for products.
- Operates in a competitive industry subject to rapid technological change, and products may not be competitive with other alternatives.
- May not be able to successfully enhance product offerings through research and development efforts.
- Real or perceived design flaws, errors, defects, glitches, bugs, or malfunctions in AI/ML Foundational Technology and related products could result in lower customer ROI, personal injury, property damage, and significant security or safety concerns.
- Use of 'open source' software could negatively affect the ability to offer AI/ML Foundational Technology and related products and subject the company to possible litigation.
- Business and prospects depend significantly on the ability to build its brand, which could be harmed by negative publicity.
- Management team's strategic decisions may not always lead to desired results or may have unintended negative consequences.
- Failure to effectively manage the business may prevent successful development, marketing, and commercialization of software products.
- Inability to adequately control the costs associated with operations to achieve profitability.
- Expects to incur substantial research and development costs and may never reach profitability or achieve significant licensing revenue.
- Business plans require a significant amount of capital; potential sale of additional equity or debt securities may dilute stockholders or introduce restrictive covenants.
- Financial results may vary significantly from period to period due to fluctuations in operating costs, revenues, and product demand.
- High dependence on senior management and other key employees; inability to attract, integrate, and retain qualified employees could harm the business.
- Failure to maintain and strengthen effective systems of disclosure controls and procedures and internal control over financial reporting could adversely affect the ability to produce timely and accurate financial statements.
- Subject to risks associated with strategic relationships, acquisitions, or transactions, and may not identify or form desired strategic relationships in the future.
- May become subject to new or changing governmental regulations relating to AI/ML development, marketing, licensing, distribution, or use, or customer service, leading to delays, increased costs, or making the business unviable.
- Issues in the development and use of AI/ML, combined with an uncertain regulatory environment, may result in reputational harm, liability, or other adverse consequences.
- Changes in tax laws could have a material adverse effect on the business, cash flows, results of operations, or financial condition.
- Increased scrutiny and changing expectations from regulators, investors, customers, employees, and others regarding environmental, social, and governance (ESG) practices and reporting.
- Success depends in part on the ability to obtain and maintain protection for intellectual property relating to software and other technologies.
- May not be able to effectively protect intellectual property rights in target markets or at all.
- May be subject to intellectual property infringement or misappropriation claims, which may be time-consuming and expensive.
- Intellectual property discovered through government-funded programs may be subject to federal regulations such as 'march-in' rights, certain reporting requirements, and a preference for U.S.-based companies.
- May be subject to damages resulting from claims of wrongful use or disclosure of alleged trade secrets of employees' former employers.
- The issuance or sale of shares of Common Stock, or rights to acquire shares, could depress the trading price and cause dilution to existing stockholders.
- The price of Common Stock could decline due to the large number of shares subject to employee equity awards.
- The markets for publicly traded securities have been volatile and may not continue at all.
- Publicly traded securities are subject to potential delisting from The Nasdaq Global Market if continued listing requirements are not met.
- There is no guarantee that the deSPAC Public Warrants or the deSPAC Private Placement Warrants will ever be in the money, and they may expire worthless.
- The company may redeem unexpired deSPAC Warrants prior to their exercise at a time that is disadvantageous to deSPAC Warrant holders.
- Exercise of deSPAC Warrants and 2024 Warrants would increase the number of shares eligible for future resale and result in dilution to stockholders.
- Anti-takeover provisions contained in the Charter and Bylaws, as well as provisions of Delaware law, could impair a takeover attempt.
- Bylaws provide that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for certain stockholder litigation matters, and federal district courts for Securities Act claims.
- As an 'emerging growth company,' the company takes advantage of certain exemptions from various reporting requirements, which may make its stock less attractive to some investors.
Future Outlook
The company expects to incur significant losses for the foreseeable future and its ability to generate positive cash flow remains uncertain. It anticipates beginning to generate revenues from commercial customers in the first half of 2026, with sales cycles for Palladyne IQ estimated at 12-18 months or longer, and unknown for Palladyne Pilot. The company believes it has sufficient financial resources for at least the next 12 months but may seek additional financing opportunistically to bolster cash reserves and pursue business objectives. Substantial research and development costs are expected to continue as the company focuses on enhancing and commercializing its AI/ML Foundational Technology and related products.
Management Comments
- Our mission is to deliver artificial intelligence software products that enable robotic and unmanned platforms, or robotic systems, in the industrial and defense sectors to perform complex tasks in arbitrary (i.e., unstructured and dynamic) human environments.
- We believe this 'human-like' ability to learn, reason and adapt will be a key differentiator in assisting our customers to enhance productivity in dynamic or unstructured environments, where human reasoning has traditionally been required to complete the task.
- We designed our AI/ML Foundational Technology to be hardware agnostic, meaning that our AI/ML software products are designed so that with a minimal integration effort they will be able to function on a wide variety of industrial robots, cobots, unmanned aerial vehicles ('UAV'), unmanned ground vehicles ('UGV') and other remotely operated vehicles ('ROV').
- We expect to begin generating revenues from commercial customers in the first half of 2026.
- We believe we have sufficient liquidity to operate for at least the next 12 months without the need to raise additional capital.
- We may decide to seek additional financing during that time to bolster our cash reserves and increase our ability to continue to pursue our business objectives.
- We intend to continue monitoring our liquidity, financial and business results and outlook and market conditions, and may be opportunistic and raise capital when we consider market conditions are good or a favorable opportunity exists.
Industry Context
Palladyne AI operates in the rapidly evolving AI/ML software and robotics industries, aiming to provide hardware-agnostic autonomy software for industrial and defense robotic systems. This positions the company within a growing market for AI-enhanced automation, where its 'human-like' learning capabilities are intended as a key differentiator. The competitive landscape includes specialized AI/ML software firms and larger industrial robotics manufacturers and technology companies, which could be both partners and competitors. The company's strategic pivot from hardware to software aligns with broader industry trends towards software-defined solutions and AI integration. Changes in U.S. trade policy are noted as potentially delaying near-term automation investments but creating greater long-term opportunities domestically.
Comparison to Industry Standards
- The company believes its competitors are primarily focused on particular aspects of AI/ML functionality rather than offering a fully competitive, comprehensive solution like its AI/ML Foundational Technology.
- Potential competitors include specialized AI/ML software companies such as Bright Machines, Intrinsic, Liquid AI, Mujin, Physical Intelligence, Rapid Robotics, Skild AI, Anduril, and Shield AI.
- Industrial robotics and cobot manufacturers (e.g., ABB, Fanuc, Kawasaki, KUKA, Universal Robots, Yasakawa) and large system integrators (e.g., Honeywell, Reply, Rockwell Automation) are identified as potential customers/partners, but also as formidable competitors through their own development or acquisitions.
- Technology companies like NVIDIA are also recognized as potential competitors due to their robust customer relationships, channels, and significant financial resources.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President and Chief Executive Officer | NA | Benjamin G. Wolff | February 2024 | Rejoined executive team following the pivot in business focus to AI/ML Foundational Technology. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Policy Update | Amended and Restated Outside Director Compensation Policy became effective, formalizing cash and equity compensation for non-employee directors. | April 7, 2025 | Aims to attract, retain, and reward Outside Directors by providing competitive compensation, potentially enhancing board quality and oversight. |
| Bylaw Amendment (Forum Selection) | Bylaws designate the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain stockholder litigation matters. | NA | May limit stockholders' ability to choose a favorable judicial forum for disputes, potentially discouraging certain lawsuits and centralizing legal proceedings. |
| Bylaw Amendment (Forum Selection) | Bylaws designate federal district courts of the United States as the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. | NA | Aims to streamline litigation related to federal securities laws, but its enforceability for Securities Act claims is uncertain and could lead to additional costs if challenged. |
Legal Proceedings
- Not currently a party to or aware of any proceedings that are believed to have a material adverse effect on the business, financial condition, or results of operations.
- Legal costs are expensed as incurred.
- No material loss contingency related to legal proceedings has been recorded in the balance sheets as of September 30, 2025, and December 31, 2024.
Related Party Transactions
- On November 1, 2024, the Chief Executive Officer and certain other members of the Board of Directors purchased 430,105 shares of common stock and warrants to purchase up to 430,105 shares of common stock in a separate concurrent private placement.
Stakeholder Impact
- Shareholders face potential dilution from future equity offerings and warrant exercises, as well as continued stock price volatility. Anti-takeover provisions in the company's governing documents could limit the premium in a potential takeover.
- Employees have experienced workforce reductions (2023 RIFs) to manage costs, which may place additional strain on existing personnel. The company's success is highly dependent on retaining senior management and key AI/ML engineers, supported by stock-based compensation plans.
- Customers may experience delays in product availability and commercialization of new AI/ML software. The company's reliance on early adopters and the impact of government shutdowns on government contracts introduce uncertainty for customer acquisition and revenue.
- Suppliers face risks due to the company's dependence on single, sole, or limited source suppliers for critical hardware components, which could lead to supply chain disruptions and increased costs.
- Creditors are not explicitly mentioned as the company has no debt, but any future debt financing could introduce restrictive covenants affecting operations.
Next Steps
- Continue commercialization efforts, internal testing, and customer trials for Palladyne IQ and Palladyne Pilot through the remainder of 2025.
- Continue to enhance software products, conduct product development activities, and pursue marketing and sales opportunities.
- Continue product testing, debugging, and stabilization efforts for current products.
- Conduct product development efforts for the next versions of products.
- Monitor liquidity, financial and business results, and market conditions for potential opportunistic capital raises.
- Evaluate obligations and develop a plan to ensure compliance with the AI Act and other AI/ML related legislation/regulations.
- Go through a recertification process periodically for CMMC program requirements.
Key Dates
| Date | Description |
|---|---|
| January 20, 2021 | Rotor Acquisition Corp. consummated its initial public offering (IPO). |
| April 5, 2021 | Date of the Original Merger Agreement between Rotor Acquisition Corp. and Sarcos Corp. |
| August 28, 2021 | Date of Amendment No. 1 to the Merger Agreement. |
| September 24, 2021 | Closing Date of the Business Combination between Rotor Acquisition Corp. and Old Sarcos, with Rotor changing its name to Sarcos Technology and Robotics Corporation. |
| January 1, 2023 | California Privacy Rights Act (CPRA) went into effect. |
| December 31, 2023 | Balance sheet date for comparative stockholders' equity data. |
| February 2024 | Benjamin G. Wolff rejoined the executive team as President and Chief Executive Officer. |
| March 2024 | Company changed its name from Sarcos Technology and Robotics Corporation to Palladyne AI Corp. |
| March 13, 2024 | European Parliament adopted the European Union's Artificial Intelligence Act (AI Act). |
| March 31, 2024 | Balance sheet date for comparative stockholders' equity data. |
| April 17, 2024 | Company amended certain stock options, reducing the per share exercise price to $1.59. |
| June 30, 2024 | Balance sheet date for comparative stockholders' equity data. |
| September 30, 2024 | End of comparative quarterly period for financial statements and balance sheet date for comparative stockholders' equity data. |
| October 30, 2024 | Consolidated closing bid price of the company's common stock on Nasdaq Global Market was $2.20. |
| October 31, 2024 | Company announced raising approximately $7 million in gross proceeds from the sale of Common Stock and warrants. |
| November 1, 2024 | Company closed a registered direct offering and concurrent private placement for 2024 Private Placement Warrants. |
| November 13, 2024 | Company entered into an 'at-the-market' equity offering program with Jefferies LLC for up to $18.0 million of shares. |
| December 1, 2024 | Offering periods under the 2021 Employee Stock Purchase Plan (ESPP) commenced. |
| December 15, 2024 | Effective date of the 2024 Inducement Equity Incentive Plan. |
| December 31, 2024 | Balance sheet date for comparative financial statements; all $18.0 million shares under the November 13, 2024 prospectus supplement were sold; filed prospectus supplement for an additional $30.0 million of shares. |
| February 20, 2025 | Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, was filed with the SEC. |
| March 31, 2025 | Balance sheet date for comparative stockholders' equity data. |
| April 7, 2025 | Effective date of the Amended and Restated Outside Director Compensation Policy. |
| April 10, 2025 | Received Level 2 certification for Cybersecurity Maturity Model Certification (CMMC) program requirements. |
| May 9, 2025 | 2,790,700 of the 2024 Private Placement Warrants were exercised. |
| June 1 | Offering periods under the ESPP begin. |
| June 28, 2025 | G7 released a joint statement announcing an understanding regarding a proposed 'side-by-side' solution for global minimum tax initiative. |
| June 30, 2025 | Balance sheet date for comparative stockholders' equity data. |
| July 4, 2025 | President Trump signed the One Big Beautiful Bill Act, including tax reform provisions. |
| August 6, 2025 | Company filed a prospectus supplement for an additional $50.0 million of shares under the 'at-the-market' Sales Agreement. |
| September 24, 2025 | Four-year anniversary of the Business Combination Closing Date, resulting in the expiration of 2,343,750 Earn-Out Shares. |
| September 30, 2025 | End of the current quarterly period for financial statements. |
| November 12, 2025 | Date of filing this Quarterly Report on Form 10-Q. |
| January 1, 2026 | Effective date for ASU 2023-09 (Income Taxes) for annual periods. |
| January 20, 2026 | Fifth anniversary of Rotor's initial public offering, relevant for Emerging Growth Company status determination. |
| August 2, 2026 | The European Union's Artificial Intelligence Act (AI Act) is scheduled to become effective over time through this date. |
| September 24, 2026 | DeSPAC Warrants will expire. |
| December 15, 2026 | Effective date for ASU 2024-03 (Income Statement Expenses) for fiscal years. |
| December 31, 2026 | Latest date the company expects to remain an Emerging Growth Company. |
| December 15, 2027 | Effective date for ASU 2024-03 (Income Statement Expenses) for interim periods. |
Recommendation
holdPalladyne AI is in a critical transitional phase, pivoting from legacy hardware to AI/ML software. While the company has significantly improved its quarterly net loss and reported a net income for the nine-month period, this is largely attributable to non-cash gains on warrant liabilities rather than core operational profitability. Revenue from its new AI/ML products has yet to materialize, and the company continues to incur substantial operating losses and negative cash flows from operations. Recent capital raises have bolstered liquidity, providing a runway for at least 12 months. However, the company faces significant risks inherent in early-stage software commercialization, including long and uncertain sales cycles, intense competition, and an evolving regulatory landscape for AI. For existing investors, a 'hold' is appropriate given the potential long-term upside of its AI technology, balanced against the high execution risk and lack of proven commercial success in its new direction. New investors should approach with caution due to the speculative nature and significant uncertainties.
Keywords
AI/ML Foundational Technology, Robotics, Artificial Intelligence, Machine Learning, Software Licensing, Industrial Automation, Unmanned Systems, Palladyne IQ, Palladyne Pilot, SEC Filing, 10-Q, Financial Results, Early Stage Company, Commercialization, Corporate Governance, Risk Management, Nasdaq
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.